UroGen Pharma EPS URGN

Diluted earnings per share by quarter and over the last twelve months, from 2018.

UroGen Pharma's earnings per share was −$4.96 over the twelve months to Dec 31, 2021.

In its latest quarter, Q4 FY21, it was −$1.27.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q4 FY21	Dec 31, 2021	−$1.27	n/a	−$4.96
Q3 FY21	Sep 30, 2021	−$1.35	n/a	−$5.07
Q2 FY21	Jun 30, 2021	−$1.17	n/a	−$5.03
Q1 FY21	Mar 31, 2021	−$1.17	n/a	−$5.30
Q4 FY20	Dec 31, 2020	−$1.38	n/a	−$5.92
Q3 FY20	Sep 30, 2020	−$1.31	n/a	−$6.40
Q2 FY20	Jun 30, 2020	−$1.44	n/a	−$6.15
Q1 FY20	Mar 31, 2020	−$1.79	−261%	−$5.79
Q4 FY19	Dec 31, 2019	−$1.86	n/a	−$2.89
Q3 FY19	Sep 30, 2019	−$1.06	n/a	−$2.49
Q2 FY19	Jun 30, 2019	−$1.08	n/a	−$2.71
Q1 FY19	Mar 31, 2019	$1.11	+26%	−$2.77

Companies in Drug Manufacturers - General nearest UroGen Pharma's size, closest first, today.

Company	EPS, 12 months	Growth
URGNUroGen Pharma	n/m
ANIPANI Pharmaceuticals	$4.70
PAHCPhibro Animal Health	$2.44	+107% a year
ANABAnaptysbio	$4.57
PCRXPacira BioSciences	$0.35
HRMYHarmony Biosciences	$3.09	−0% a year
PBHPrestige Consumer Healthcare	$3.57	−16% a year
OMEROmeros	$1.52
AMPHAmphastar Pharmaceuticals	$1.70	−36% a year
NRIXNurix Therapeutics	$2.31
ABUSArbutus Biopharma	$0.78
Peer median	$2.38